Matches in Wikidata for { <http://www.wikidata.org/entity/Q62641752> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q62641752 description "artículu científicu espublizáu n'agostu de 2013" @default.
- Q62641752 description "im August 2013 veröffentlichter wissenschaftlicher Artikel" @default.
- Q62641752 description "scientific article published on 01 August 2013" @default.
- Q62641752 description "wetenschappelijk artikel" @default.
- Q62641752 description "наукова стаття, опублікована в серпні 2013" @default.
- Q62641752 name "Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, t" @default.
- Q62641752 name "Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, t" @default.
- Q62641752 type Item @default.
- Q62641752 label "Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, t" @default.
- Q62641752 label "Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, t" @default.
- Q62641752 prefLabel "Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, t" @default.
- Q62641752 prefLabel "Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, t" @default.
- Q62641752 P1433 Q62641752-963AB368-5B80-4AD0-98C3-8A2164DF8D99 @default.
- Q62641752 P1476 Q62641752-D1844454-3DAC-4683-AFE7-2359DA059CC8 @default.
- Q62641752 P2093 Q62641752-0159BA14-CFE7-49F7-A5F4-41186E1CB56E @default.
- Q62641752 P2093 Q62641752-4038423B-E55B-4CEE-B37D-60F76A872DFD @default.
- Q62641752 P2093 Q62641752-71F02114-549F-4549-AB4F-83BEA8D13B1E @default.
- Q62641752 P2093 Q62641752-7C2A9716-D075-4844-BF07-B2E3FDAEE86C @default.
- Q62641752 P2093 Q62641752-B525C219-515F-4264-AD23-54DF94058A17 @default.
- Q62641752 P2093 Q62641752-DE9AC38A-7B5F-4419-8EB0-0D8E274BC955 @default.
- Q62641752 P2093 Q62641752-E229A6E5-FCFC-4A07-9B96-E4CCED2690F9 @default.
- Q62641752 P2093 Q62641752-E3BD0257-79F9-44BB-B2A7-5A8F5299CE81 @default.
- Q62641752 P2093 Q62641752-F3F7C079-1211-49F7-ACED-DA54BAC3CC92 @default.
- Q62641752 P304 Q62641752-2EC42BD1-6A95-4B90-A524-8593CB97DF1C @default.
- Q62641752 P31 Q62641752-86D7C4C2-1B29-416D-9166-2628172DB44A @default.
- Q62641752 P356 Q62641752-9DB00F56-966F-4C40-9CD4-B4A6498EA671 @default.
- Q62641752 P407 Q62641752-B7DD08F3-A3E1-4607-A617-D7D9C79B21B6 @default.
- Q62641752 P433 Q62641752-561B5935-51E3-4025-932F-8F0CEDE5A0B1 @default.
- Q62641752 P478 Q62641752-58A57F12-C46D-4AA7-90E5-58AA505E9F31 @default.
- Q62641752 P50 Q62641752-1D428AFB-CB51-4241-9E45-9C87D4A7C9C9 @default.
- Q62641752 P50 Q62641752-1E194F2B-DDF5-4762-9F74-38C60C2ED336 @default.
- Q62641752 P50 Q62641752-64AC6582-7F10-4A91-9F1E-14D60DE51E18 @default.
- Q62641752 P50 Q62641752-C2D777F0-D556-4666-B160-6283F69B3483 @default.
- Q62641752 P50 Q62641752-E846A584-4894-434E-80A0-C851BBAA4D1D @default.
- Q62641752 P577 Q62641752-77BFCA4A-218C-4020-AA8F-6B9A427116C5 @default.
- Q62641752 P698 Q62641752-0787E134-9A37-4233-B68E-696F432AF230 @default.
- Q62641752 P921 Q62641752-CD4051FF-271A-4144-9433-C537E2982F1F @default.
- Q62641752 P356 ANNRHEUMDIS-2013-203497 @default.
- Q62641752 P698 23908187 @default.
- Q62641752 P1433 Q4767876 @default.
- Q62641752 P1476 "Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial" @default.
- Q62641752 P2093 "Anna Karjalainen" @default.
- Q62641752 P2093 "Kari Laiho" @default.
- Q62641752 P2093 "Marjatta Leirisalo-Repo" @default.
- Q62641752 P2093 "Markku Korpela" @default.
- Q62641752 P2093 "Mikko Hakola" @default.
- Q62641752 P2093 "NEO-RACo Study Group" @default.
- Q62641752 P2093 "Pekka Hannonen" @default.
- Q62641752 P2093 "Ritva Peltomaa" @default.
- Q62641752 P2093 "Vappu Rantalaiho" @default.
- Q62641752 P304 "1954-1961" @default.
- Q62641752 P31 Q13442814 @default.
- Q62641752 P356 "10.1136/ANNRHEUMDIS-2013-203497" @default.
- Q62641752 P407 Q1860 @default.
- Q62641752 P433 "11" @default.
- Q62641752 P478 "73" @default.
- Q62641752 P50 Q106596432 @default.
- Q62641752 P50 Q115280869 @default.
- Q62641752 P50 Q42340042 @default.
- Q62641752 P50 Q59169124 @default.
- Q62641752 P50 Q90730127 @default.
- Q62641752 P577 "2013-08-01T00:00:00Z" @default.
- Q62641752 P698 "23908187" @default.
- Q62641752 P921 Q187255 @default.